Latest Neurostimulation Stories

[193 Pages Report] Neuromodulation market report categorizes the global market on the basis of (Spinal Cord, Vagus Nerve, Deep Brain, Sacral Nerve & Transcranial Magnetic) Stimulation by procedure, technology and application forecasting 2012 - 2017. (PRWEB) April 28, 2013 Neuromodulation Market – [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS) & Transcranial Magnetic...

Anchoring and multiple lead placement Two innovative techniques in the placement of an implanted spinal cord stimulator (SCS) are expected to reduce common complications at the implant site, according to new research revealed today. Results from a case series highlighted an advanced lead anchoring technique and the emerging technology of using large single-port introducers, which enable placement of multiple neurostimulation leads through a single needle-entry point. Neurostimulation...

Revolutionary Migraine treatment is Less Invasive, provides better pain coverage, results in faster recovery using 32 contact Boston Scientific Spectra System Washington, DC (PRWEB) February 25, 2013 Nameer Haider, M.D., Director Interventional Pain Management at the Minimally Invasive Pain Institute has begun performing 360 Degree Neurostimulator Implantations to treat chronic headaches using the Boston Scientific Spectra System. Dr. Haider, a board certified interventional pain surgeon,...

Some 90,000 patients per year are treated for Parkinson's disease, a number that is expected to rise by 25 percent annually. Deep Brain Stimulation (DBS), which consists of electrically stimulating the central or peripheral nervous system, is currently standard practice for treating Parkinson's, but it can involve long, expensive surgeries with dramatic side effects. Miniature, ultra-flexible electrodes developed in Switzerland, however, could be the answer to more successful treatment for...

[193 Pages Report] Neuromodulation devices market report categorizes the global market of Spinal Cord Stimulation, Vagus Nerve Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation & Trans-cranial Magnetic Stimulation by procedure, technology, and application. (PRWEB) January 28, 2013 The “Neuromodulation Market – [Spinal Cord Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation & Trans-cranial Magnetic...

DALLAS, January 14, 2013 /PRNewswire/ -- The "Neuromodulation Market - [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS) & Transcranial Magnetic Stimulation (TMS)] - Forecasts to 2017" analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, APAC, and Rest of the World. Browse market 93 data tables, 4 figures...

A recently added market report by Transparency Market Research on “Neurostimulation Market - Advanced Technologies, Global Market And Industry Analysis, Size, Trends And Forecast, 2012 - 2018" is now available for pre order. To Browse the report visit: http://www.transparencymarketresearch.com/neurostimulation-market.html Albany, New york (PRWEB) January 01, 2013 Driven by rising health awareness and continuous disruptive innovations made in the field of medical and biological...

HOUSTON, Sept. 20, 2012 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced an initial investment of EUR 2 million in cerbomed GmbH ("cerbomed"). Based in Erlangen, Germany, cerbomed is a privately-held company developing a non-invasive neurostimulation device for the treatment of epilepsy. The NEMOS(®) t-VNS device received CE Mark approval for the treatment of epilepsy and depression in...

Study Will Investigate Device Therapy for Post-Stroke Shoulder Pain CLEVELAND, Sept. 20, 2012 /PRNewswire-USNewswire/ -- SPR Therapeutics, an innovator in the application of electrical stimulation to peripheral nerves for the relief of pain, has earned Investigational Device Exemption (IDE) approval from the Food and Drug Administration to initiate a multi-center, pivotal study of the SMARTPATCH(TM) Peripheral Nerve Stimulation (PNS) System for the treatment of post-stroke shoulder...